Literature DB >> 29487943

Rasch analysis of the UK Functional Assessment Measure in patients with complex disability after stroke.

Oleg N Medvedev1, Lynne Turner-Stokes, Stephen Ashford, Richard J Siegert.   

Abstract

OBJECTIVES: To determine whether the UK Functional Assessment Measure (UK FIM+FAM) fits the Rasch model in stroke patients with complex disability and, if so, to derive a conversion table of Rasch-transformed interval level scores.
METHODS: The sample included a UK multicentre cohort of 1,318 patients admitted for specialist rehabilitation following a stroke. Rasch analysis was conducted for the 30-item scale including 3 domains of items measuring physical, communication and psychosocial functions. The fit of items to the Rasch model was examined using 3 different analytical approaches referred to as "pathways".
RESULTS: The best fit was achieved in the pathway where responses from motor, communication and psychosocial domains were summarized into 3 super-items and where some items were split because of differential item functioning (DIF) relative to left and right hemisphere location (χ2 (10) = 14.48, p = 0.15). Re-scoring of items showing disordered thresholds did not significantly improve the overall model fit.
CONCLUSION: The UK FIM+FAM with domain super-items satisfies expectations of the unidimensional Rasch model without the need for re-scoring. A conversion table was produced to convert the total scale scores into interval-level data based on person estimates of the Rasch model. The clinical benefits of interval-transformed scores require further evaluation.

Entities:  

Year:  2018        PMID: 29487943     DOI: 10.2340/16501977-2324

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  1 in total

1.  Item Difficulties of the FIM-Motor Subscale in Patients with Ischemic Stroke during Acute Care: An Ordinal Logistic Modeling Study.

Authors:  Kensaku Uchida; Yuki Uchiyama; Kazuhisa Domen; Tetsuo Koyama
Journal:  Prog Rehabil Med       Date:  2020-09-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.